ClinicalTrials.Veeva

Menu

Emerging Biomarkers in Hypertension

U

University of Pavia

Status

Unknown

Conditions

Hypertension

Treatments

Drug: Anti-hypertensive drugs

Study type

Observational

Funder types

Other

Identifiers

NCT02064218
20070002649

Details and patient eligibility

About

First of all to evaluate the relationship between non-conventional biomarkers and essential hypertension; then to evaluate the effects of various anti-hypertensive drugs on blood pressure control and non-conventional biomarkers in naive hypertensive patients

Sex

All

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • essential hypertension
  • naive to treatment
  • < 65 years

Exclusion criteria

  • secondary hypertension
  • previous cardiovascular events

Trial design

0 participants in 2 patient groups

Hypertensive patients
Description:
Hypertensive patients naive to hypertensive treatment
Treatment:
Drug: Anti-hypertensive drugs
healthy subjects
Description:
healthy subjects

Trial contacts and locations

1

Loading...

Central trial contact

Giuseppe Derosa, MD, PhD; Amedeo Mugellini, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems